Clinical Trials Browser

Phase 1/2 × Interventional × Radioimmunotherapy × Clear all

NCT00302757 2014-05-29

Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma

Phase 1/2 Completed

Lymphoma, Non-Hodgkin